HKeyBio Revolutionizes Drug Research with Launch of World's First NHP In Vitro Model HKeyBio has unveiled the pioneering HKEY-NHP-onChip™ 1.1, the first non-human primate model for autoimmune and allergic diseases, boosting research efficiency.

HKeyBio Revolutionizes Drug Research with Launch of World's First NHP In Vitro Model #China #Suzhou #Autoimmune_Diseases #HKeyBio #NHP_in_vitro_model

A New Approach to Overcoming Challenges in Asthma and Allergy Drug Development: HKEY-AIRx™1.0 HKeyBio introduces HKEY-AIRx™1.0, a novel preclinical strategy aimed at enhancing the success of asthma and allergy drug programs by addressing core challenges in biotech development.

A New Approach to Overcoming Challenges in Asthma and Allergy Drug Development: HKEY-AIRx™1.0 #USA #Boston #Allergy #HKeyBio #asthma

HKeyBio Unveils Revolutionary Non-Human Primate Disease Model Matrix for Clinical Research HKeyBio has launched the HKEY-NHP-MATRIX2.0, a cutting-edge platform designed to enhance the translation of autoimmune and allergic disease treatments from research to clinical settings.

HKeyBio Unveils Revolutionary Non-Human Primate Disease Model Matrix for Clinical Research #USA #Boston #HKeyBio #Autoimmune_Research #Clinical_Translation